Håkan Norell

2.6k total citations
26 papers, 2.2k citations indexed

About

Håkan Norell is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Håkan Norell has authored 26 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Håkan Norell's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (14 papers) and CAR-T cell therapy research (8 papers). Håkan Norell is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (14 papers) and CAR-T cell therapy research (8 papers). Håkan Norell collaborates with scholars based in Sweden, United States and Portugal. Håkan Norell's co-authors include Bruno Silva‐Santos, Karine Serre, Rolf Kiessling, Karl‐Johan Malmberg, Mattias Carlsten, Kjell Schedvins, Isabel Poschke, Mikael Hanson, Hans‐Gustaf Ljunggren and Yenan T. Bryceson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Håkan Norell

26 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Håkan Norell Sweden	23	1.7k	1.0k	463	123	120	26	2.2k
Helena Harlin United States	16	1.6k 1.0×	1.3k 1.3×	742 1.6×	145 1.2×	185 1.5×	25	2.4k
José A. Guevara-Patiño United States	24	1.7k 1.0×	809 0.8×	522 1.1×	162 1.3×	57 0.5×	54	2.2k
Amy Wesa United States	21	1.3k 0.8×	711 0.7×	494 1.1×	189 1.5×	86 0.7×	35	1.9k
Belinda Palermo Italy	20	1.4k 0.8×	705 0.7×	304 0.7×	73 0.6×	90 0.8×	42	1.9k
Suman Mitra United States	19	937 0.6×	511 0.5×	367 0.8×	88 0.7×	115 1.0×	28	1.4k
Ignacio Moraga United States	22	1.3k 0.8×	957 1.0×	680 1.5×	116 0.9×	83 0.7×	34	2.2k
Zoë Johnson Switzerland	19	1.2k 0.7×	1.2k 1.2×	1000 2.2×	79 0.6×	121 1.0×	43	2.6k
Michael Gobert France	12	2.0k 1.2×	1.0k 1.0×	672 1.5×	139 1.1×	88 0.7×	14	2.6k
Rosa Molfetta Italy	26	1.3k 0.8×	665 0.7×	616 1.3×	55 0.4×	138 1.1×	57	2.0k
Mathieu Bléry France	24	2.6k 1.5×	899 0.9×	461 1.0×	66 0.5×	203 1.7×	44	3.1k

Countries citing papers authored by Håkan Norell

Since Specialization

Citations

This map shows the geographic impact of Håkan Norell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkan Norell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkan Norell more than expected).

Fields of papers citing papers by Håkan Norell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Håkan Norell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkan Norell. The network helps show where Håkan Norell may publish in the future.

Co-authorship network of co-authors of Håkan Norell

This figure shows the co-authorship network connecting the top 25 collaborators of Håkan Norell. A scholar is included among the top collaborators of Håkan Norell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Håkan Norell. Håkan Norell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Johanna, Inez, Trudy Straetemans, Sabine Heijhuurs, et al.. (2019). Evaluating in vivo efficacy – toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells. Journal for ImmunoTherapy of Cancer. 7(1). 69–69. 44 indexed citations

2.

Caiado, Francisco, Diogo Maia-Silva, Nina Schmolka, et al.. (2019). Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection. Nature Communications. 10(1). 4986–4986. 27 indexed citations

3.

Nóbrega‐Pereira, Sandrina, Francisco Caiado, Tânia Carvalho, et al.. (2017). VEGFR2–Mediated Reprogramming of Mitochondrial Metabolism Regulates the Sensitivity of Acute Myeloid Leukemia to Chemotherapy. Cancer Research. 78(3). 731–741. 26 indexed citations

4.

Caiado, Francisco, Bruno Silva‐Santos, & Håkan Norell. (2016). Intra‐tumour heterogeneity – going beyond genetics. FEBS Journal. 283(12). 2245–2258. 56 indexed citations

5.

Meyers‐Needham, Marisa, Salih Gencer, R. David Sentelle, et al.. (2012). Off-Target Function of the Sonic Hedgehog Inhibitor Cyclopamine in Mediating Apoptosis via Nitric Oxide–Dependent Neutral Sphingomyelinase 2/Ceramide Induction. Molecular Cancer Therapeutics. 11(5). 1092–1102. 33 indexed citations

6.

Naga, Osama, Håkan Norell, Amir A. Al-Khami, et al.. (2011). T cells expanded in presence of IL-15 exhibit increased antioxidant capacity and innate effector molecules. Cytokine. 55(2). 307–317. 32 indexed citations

7.

Norell, Håkan, Isabel Poschke, Jehad Charo, et al.. (2010). Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial. Journal of Translational Medicine. 8(1). 53–53. 99 indexed citations

8.

Norell, Håkan, Yi Zhang, James McCracken, et al.. (2010). CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting. Cancer Immunology Immunotherapy. 59(6). 851–862. 33 indexed citations

9.

Carlsten, Mattias, Håkan Norell, Yenan T. Bryceson, et al.. (2009). Primary Human Tumor Cells Expressing CD155 Impair Tumor Targeting by Down-Regulating DNAM-1 on NK Cells. The Journal of Immunology. 183(8). 4921–4930. 224 indexed citations

10.

Ando, Takashi, Kousaku Mimura, C. Christian Johansson, et al.. (2008). Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative Stress. The Journal of Immunology. 181(12). 8382–8390. 86 indexed citations

11.

Kruschinski, Anna, Andreas Moosmann, Isabel Poschke, et al.. (2008). Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas. Proceedings of the National Academy of Sciences. 105(45). 17481–17486. 158 indexed citations

12.

Vertuani, Simona, Jehad Charo, Håkan Norell, et al.. (2008). HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice. Cancer Immunology Immunotherapy. 58(5). 653–664. 48 indexed citations

13.

Carlsten, Mattias, Niklas K. Björkström, Håkan Norell, et al.. (2007). DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells. Cancer Research. 67(3). 1317–1325. 189 indexed citations

14.

Harlin, Helena, Mikael Hanson, C. Christian Johansson, et al.. (2007). The CD16−CD56bright NK Cell Subset Is Resistant to Reactive Oxygen Species Produced by Activated Granulocytes and Has Higher Antioxidative Capacity Than the CD16+CD56dim Subset. The Journal of Immunology. 179(7). 4513–4519. 65 indexed citations

15.

Norell, Håkan, Mattias Carlsten, Karl‐Johan Malmberg, et al.. (2006). Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/neu-Specific Immunity. Cancer Research. 66(12). 6387–6394. 52 indexed citations

16.

Kaplan, Barbara L.F., et al.. (2005). Interferon-γ renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells. Cancer Immunology Immunotherapy. 55(6). 653–662. 8 indexed citations

17.

Takahashi, Akihiro, Mikael Hanson, Håkan Norell, et al.. (2005). Preferential Cell Death of CD8+ Effector Memory (CCR7−CD45RA−) T Cells by Hydrogen Peroxide-Induced Oxidative Stress. The Journal of Immunology. 174(10). 6080–6087. 92 indexed citations

18.

Zuber, Bartek, Victor Levitsky, Gun Jönsson, et al.. (2005). Detection of human perforin by ELISpot and ELISA: Ex vivo identification of virus-specific cells. Journal of Immunological Methods. 302(1-2). 13–25. 45 indexed citations

19.

Malmberg, Karl‐Johan, Victor Levitsky, Håkan Norell, et al.. (2002). IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. Journal of Clinical Investigation. 110(10). 1515–1523. 159 indexed citations

20.

Malmberg, Karl‐Johan, Victor Levitsky, Håkan Norell, et al.. (2002). IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. Journal of Clinical Investigation. 110(10). 1515–1523. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact